UNHUNITEDHEALTH GROUP INC
Hospital & Medical Service Plans
- Revenue
- $447.6B
- 12% YoY
- Operating margin
- 4.2%
- 47% YoY
- EBITDA
- $23.3B
- 36% YoY
- Market cap
- —
- Employees
- —
- Net debt / EBITDA
- 2.1×
- $49.1B net debt
- AI in 10-K
- —
Red flags 0 of 9
- TSR below peersClear—3+ of last 5 years
- High CEO pay despite TSRClear—Median CEO pay ≥ $15M and TSR flag
- Active 13DClear0 filingsActive-intent 13D in 18 months
- Net insider sellingClear$0 netNet sales over $10M in 12 months
- Earnings not backed by cashClear163% of net incomeCash flow under 80% of net income
- Dilutive SBCClear0% of revenueOver 10% of revenue
- Payouts exceed cash flowClear68% of cash flowBuybacks + dividends over cash flow
- Goodwill-heavyClear36% of assetsOver 40% of assets
- Shareholder dissentClear—Any vote under 80% support
Financials
| Metric | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 | YoY |
|---|---|---|---|---|---|---|
| Revenue | $287.6B | $324.2B | $371.6B | $400.3B | $447.6B | 12% |
| Operating income | $24.0B | $28.4B | $32.4B | $32.3B | $19.0B | 41% |
| Net income | $17.3B | $20.1B | $22.4B | $14.4B | $12.1B | 16% |
| Operating cash flow | $22.3B | $26.2B | $29.1B | $24.2B | $19.7B | 19% |
| Capex | $2.5B | $2.8B | $3.4B | $3.5B | $3.6B | 3.5% |
| Stock-based comp | $800M | $925M | $1.1B | $1.0B | $971M | 4.6% |
| Buybacks | $5.0B | $7.0B | $8.0B | $9.0B | $5.5B | 38% |
| Dividends | $5.3B | $6.0B | $6.8B | $7.5B | $7.9B | 5.1% |
Deal filings
None.
13D filers
None on file.
Insider trading
No open-market trades in the last 12 months.
Pay vs performance
| Year | CEO total comp | Comp actually paid | TSR (indexed) | Peer TSR |
|---|---|---|---|---|
| FY2025 | — | — | 102 | 148 |
| FY2024 | — | — | 153 | 129 |
| FY2023 | — | — | 157 | 126 |
| FY2022 | — | — | 155 | 124 |
| FY2021 | — | — | 145 | 126 |